Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |